CVS Health Corporation $CVS Shares Purchased by Stephens Inc. AR

Key Points

• Stephens Inc. AR increased its stake in CVS Health Corporation by 12.0% during the second quarter, owning 30,620 shares valued at approximately $2.11 million at the quarter's end.
• CVS Health's recent earnings report indicated a beat on earnings per share, with results of $1.81 compared to an estimate of $1.46, and an revenue increase of 8.4% year-over-year.
• The company announced a quarterly dividend of $0.665 per share, with a dividend yield of 3.2%, payable on November 3rd for shareholders of record on October 23rd.

Stephens Inc. AR raised its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 12.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,620 shares of the pharmacy operator's stock after purchasing an additional 3,285 shares during the quarter. Stephens Inc. AR's holdings in CVS Health were worth $2,112,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Harbor Asset Planning Inc. bought a new position in CVS Health during the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc lifted its holdings in CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock worth $31,000 after buying an additional 248 shares during the last quarter. Roxbury Financial LLC lifted its holdings in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock worth $32,000 after buying an additional 202 shares during the last quarter. ORG Partners LLC lifted its holdings in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator's stock worth $32,000 after buying an additional 377 shares during the last quarter. Finally, Saudi Central Bank bought a new position in CVS Health during the 1st quarter worth approximately $34,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director owned 22,156 shares of the company's stock, valued at $1,573,519.12. The trade was a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have commented on CVS. Cowen reaffirmed a "buy" rating on shares of CVS Health in a report on Monday, August 4th. Jefferies Financial Group increased their target price on CVS Health from $80.00 to $92.00 in a report on Wednesday, October 15th. Zacks Research downgraded CVS Health from a "strong-buy" rating to a "hold" rating in a report on Monday, September 8th. Bernstein Bank cut their price target on CVS Health from $78.00 to $72.00 and set a "market perform" rating on the stock in a report on Wednesday, July 16th. Finally, Sanford C. Bernstein raised their price target on CVS Health from $72.00 to $77.00 and gave the stock a "market perform" rating in a report on Friday, September 5th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and an average price target of $82.57.

CVS Health Stock Down 1.2%

Shares of CVS Health stock opened at $82.08 on Thursday. The business's fifty day moving average price is $75.02 and its two-hundred day moving average price is $68.45. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The company has a market capitalization of $104.11 billion, a P/E ratio of 22.93, a PEG ratio of 0.92 and a beta of 0.60. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $83.52.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.2%. CVS Health's payout ratio is presently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.